Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Thanks to the expected introduction of several late-stage pipeline products. The type 1 diabetes (T1D) market across the ...

Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully ...

According to preliminary estimates released by GlobalData, US Light Vehicle sales grew by 2.4% year-on-year in December, to 1.51 million units.

In recent years, the oil and gas industry has progressed from using digital technologies for select use cases to making their ...

It’s become evident that a cloud-based IT portfolio brings organisations the greatest promise for providing the type of ...

Lilly’s offering is expected to surpass Novo’s Wegovy in the space, and, according to a report this week from GlobalData, it ...

Operational risks are also reduced due to a lesser need for human intervention in hazardous environments, which is a very ...

The heart failure market is expected to grow at a 9.6% CAGR from $13.5bn in 2022 to $33.7bn in 2032 in the 7MM.

Consumer hesitation around taste remains a main challenge to successfully marketing alternative food and drink products, says GlobalData.